Metabolic Complications of HIV and Antiretroviral Therapy: Dyslipidemia, Insulin Resistance, and Cardiovascular Disease

  • Authors: Judith S. Currier, MD, MSc; Risa Hoffman, MD, MPH (More Info)
  • Editors in Chief: Joseph J. Eron, Jr., MD; Daniel R. Kuritzkes, MD
  • Last Reviewed: 10/10/18 (What's New)

Summary

    Risk Factors and Mechanisms of Abnormal Glucose Metabolism: HIV vs Antiretroviral TherapyScreening for Abnormal Glucose Metabolism in HIV-Infected Patients
      Treatment and Monitoring for Abnormal Glucose Metabolism
        Treatment of Abnormal Glucose Metabolism With Metformin
          Treatment of Abnormal Glucose Metabolism With Thiazolidinediones
            Treatment of Abnormal Glucose Metabolism With Sulfonylureas, Meglitinides, GLP-1 Receptor Agonists, Gliptins, and Gliflozins
              Treatment of Abnormal Glucose Metabolism by Modifying Antiretroviral Therapy
              Primary Prevention of Abnormal Glucose Metabolism
                Considerations for Resource-Limited Settings

                Action required